WO2023116060A1 - 一种结构化水凝胶和水凝胶心脏及瓣膜的制备方法 - Google Patents
一种结构化水凝胶和水凝胶心脏及瓣膜的制备方法 Download PDFInfo
- Publication number
- WO2023116060A1 WO2023116060A1 PCT/CN2022/117682 CN2022117682W WO2023116060A1 WO 2023116060 A1 WO2023116060 A1 WO 2023116060A1 CN 2022117682 W CN2022117682 W CN 2022117682W WO 2023116060 A1 WO2023116060 A1 WO 2023116060A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrogel
- water
- preparation
- structured
- density hydrogen
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
- C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F120/52—Amides or imides
- C08F120/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
- C08F120/60—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing nitrogen in addition to the carbonamido nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C64/00—Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
- B29C64/10—Processes of additive manufacturing
- B29C64/106—Processes of additive manufacturing using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material
- B29C64/124—Processes of additive manufacturing using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material using layers of liquid which are selectively solidified
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C64/00—Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
- B29C64/30—Auxiliary operations or equipment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y40/00—Auxiliary operations or equipment, e.g. for material handling
- B33Y40/20—Post-treatment, e.g. curing, coating or polishing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
- B33Y70/10—Composites of different types of material, e.g. mixtures of ceramics and polymers or mixtures of metals and biomaterials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/52—Amides or imides
- C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
- C08F220/60—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing nitrogen in addition to the carbonamido nitrogen
- C08F220/603—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing nitrogen in addition to the carbonamido nitrogen and containing oxygen in addition to the carbonamido oxygen and nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/0002—Condition, form or state of moulded material or of the material to be shaped monomers or prepolymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
- B29L2031/7532—Artificial members, protheses
- B29L2031/7534—Cardiovascular protheses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
Definitions
- the invention relates to the technical field of hydrogels, in particular to a method for preparing structured hydrogels and hydrogel hearts and valves.
- biomaterials such as polymers, ceramics, and metals have achieved rapid development and have been widely used in the medical field, greatly improving the treatment efficiency of many diseases.
- biomaterials are widely used in biomedicine, many biomaterials lack ideal functional properties (such as biomechanical matching, biocompatibility, personalized biomanufacturing, and surface-interface interactions in biological systems), making them Its application is still limited.
- Hydrogel has a hydrophilic polymer network structure, and water can penetrate between the polymer chains of the hydrophilic polymer network structure, resulting in swelling.
- the advantages of hydrogels for biological applications lie in their high water content, biomechanical compatibility, and biocompatibility.
- Traditional hydrogels are usually divided into two categories: natural hydrogels and synthetic hydrogels.
- Natural hydrogels include polysaccharides (such as cellulose, alginic acid, hyaluronic acid, chitosan, etc.) and polypeptides (such as poly-L-lysine, collagen, poly-L-glutamic acid, etc.).
- Synthetic hydrogels include alcohols, acrylic acid and their derivatives (such as polyacrylic acid, polymethacrylic acid, polyacrylamide, etc.).
- the object of the present invention is to provide a method for preparing structured hydrogel and hydrogel heart and valve.
- the structured hydrogel obtained by the preparation method provided by the invention has excellent toughness.
- the invention provides a method for preparing a structured hydrogel, comprising the following steps:
- the photocurable hydrogel ink is subjected to photocurable 3D printing to obtain a printed hydrogel;
- the photocurable hydrogel ink includes the following components: monomer, photoinitiator, dyestuff and solvent;
- the monomers include high-density hydrogen-bonding type unsaturated monomers, and the high-density hydrogen-bonding type unsaturated monomers include N-acryloyl semicarbazide, N-acryloyl glycinamide, allyl urea and allyl urea one or more of
- the solvents include water and dimethylsulfoxide.
- the monomers further include low-density hydrogen-bonding unsaturated monomers, and the low-density hydrogen-bonding unsaturated monomers include acrylamide or acrylic acid.
- the mass ratio of water and dimethyl sulfoxide in the solvent is 9:1 ⁇ 1:9.
- the photoinitiator is a water-based photoinitiator; the water-based photoinitiator includes one or more of 2959 photoinitiators, LAP photoinitiators and V-50 photoinitiators; the photoinitiator
- the mass of the monomer is 0.1-1% of the mass of the monomer.
- the mass percentage of solute in the photocurable hydrogel ink is 5-30%.
- the parameters of the photocuring 3D printing include: the wavelength of the light source is 385nm-405nm; the exposure time of each layer is 5s-60s; the slice layer thickness is 0.05mm-0.1mm.
- the time for the water immersion is 5-15 days.
- the present invention also provides a method for preparing a hydrogel heart and a valve, comprising the following steps:
- the photocurable hydrogel ink is subjected to photocurable 3D printing to obtain the printed hydrogel;
- the photocurable hydrogel ink includes the following components: monomers, RAFT reagents, photoinitiators, dyes and solvents;
- the monomers include high-density hydrogen-bonding type unsaturated monomers, and the high-density hydrogen-bonding type unsaturated monomers include N-acryloyl semicarbazide, N-acryloyl glycinamide, allyl urea and allyl urea one or more of
- the solvent includes water and dimethyl sulfoxide
- the functional monomers include sodium styrene sulfonate or heparan-like active monomers.
- the RAFT reagent is a water-soluble RAFT reagent;
- the water-soluble RAFT reagent includes 4-cyano-4-(((ethylthio)thiocarbonyl)thio)pentanoic acid, 2-(n-butyl Thiocarbonylthio)propionic acid or 4-cyano-4-((dodecylsulfanylthiocarbonyl)sulfanyl)pentanoic acid; the quality of the RAFT reagent is 0.1 ⁇ 2%.
- the temperature of the surface modification is 60-90° C., and the time is 5 min-48 h.
- the invention provides a method for preparing a structured hydrogel, comprising the following steps: providing a photocurable hydrogel ink; performing photocurable 3D printing on the photocurable hydrogel ink according to a predetermined three-dimensional digital model to obtain printing hydrogel; immersing the printed hydrogel in water to obtain the structured hydrogel;
- the photocurable hydrogel ink includes the following components: monomers, photoinitiators, dyes and solvents; the The monomers include high-density hydrogen bond type unsaturated monomers, and the high-density hydrogen bond type unsaturated monomers include N-acryloyl semicarbazide, N-acryloyl glycinamide, allyl urea and allyl urea One or more of; said solvent includes water and dimethyl sulfoxide.
- high-density hydrogen-bonding unsaturated monomers are dissolved in a mixed solvent of dimethyl sulfoxide and water to form a photocurable hydrogel ink.
- the printed hydrogel obtained is immersed in water.
- the dimethyl sulfoxide in the printed hydrogel diffuses into the water for phase inversion, so that the hydrogen bonds inside the printed hydrogel are reconstructed, and finally the toughness of the structured functional hydrogel is improved.
- the present invention also provides a method for preparing a hydrogel heart and valve, comprising the following steps: providing light-curable hydrogel ink; performing a process on the light-curable hydrogel ink according to a predetermined three-dimensional digital model of the heart and valve.
- the photocurable hydrogel ink includes the following components: monomers, RAFT reagents, photoinitiators, dyes and solvents;
- the monomers include high-density hydrogen bond type unsaturated monomers,
- the high-density hydrogen bond type unsaturated monomer includes one or more of N-acryloyl semicarbazide, N-acryloyl glycinamide, allyl urea and allyl urea;
- the solvent includes water and di Methyl sulfoxide;
- the functional monomer includes sodium styrene sulfonate or heparan-like active monomer.
- high-density hydrogen-bonding unsaturated monomers are dissolved in a mixed solvent of dimethyl sulfoxide and water to form a photocurable hydrogel ink.
- the printed hydrogel obtained is immersed in water.
- the dimethyl sulfoxide in the printed hydrogel diffuses into the water for phase inversion, so that the hydrogen bonds inside the printed hydrogel are reconstructed, and finally the toughness of the structured functional hydrogel is improved.
- Using sodium styrene sulfonate or heparan-like active monomers to modify the surface of the structured hydrogel can improve the cytocompatibility, blood compatibility and tissue compatibility of the hydrogel heart and valves.
- Fig. 1 is the preparation schematic diagram of the structured hydrogel provided by the present invention.
- Fig. 2 is the optical photo of the structured hydrogel prepared in Example 1;
- Figure 3 is a diagram of the mechanical properties of the structured hydrogel prepared in Example 1;
- Figure 4 is a diagram of the mechanical properties of the structured hydrogel prepared in Example 2.
- Figure 5 is a diagram of the mechanical properties of the structured hydrogel prepared in Example 3.
- Figure 6 is a diagram of the mechanical properties of the structured hydrogel prepared in Example 3.
- Figure 7 is an optical photograph of the structured hydrogel prepared in Example 5.
- Figure 8 is a diagram of the mechanical properties of the structured hydrogel prepared in Example 5.
- Figure 9 is a diagram of the mechanical properties of the structured hydrogel prepared in Comparative Example 1;
- Fig. 10 is the optical photograph of the hydrogel heart valve that embodiment 7 prepares
- Fig. 11 is the mechanical properties diagram of the hydrogel heart valve prepared in Example 7.
- Fig. 12 is the optical photograph of the tubular hydrogel heart valve that embodiment 8 prepares
- Fig. 13 is the optical photograph of the heart that embodiment 8 prepares
- Fig. 14 is a diagram of the mechanical properties of the hydrogel heart valve prepared in Example 9;
- Figure 15 is a diagram of the mechanical properties of the hydrogel heart valve prepared in Example 10.
- Figure 16 is an optical photo of the hydrogel heart valve prepared in Example 11;
- Figure 17 is a diagram of the mechanical properties of the hydrogel heart valve prepared in Comparative Example 4.
- FIG. 18 is a diagram of the mechanical properties of the hydrogel heart valve prepared in Comparative Example 5.
- the invention provides a method for preparing a structured functional hydrogel, comprising the following steps:
- the photocurable hydrogel ink is subjected to photocurable 3D printing to obtain a printed hydrogel;
- the photocurable hydrogel ink includes the following components: monomer, photoinitiator, dyestuff and solvent;
- the monomers include high-density hydrogen-bonding unsaturated monomers, and the high-density hydrogen-bonding unsaturated monomers include N-acryloyl semicarbazide (C 4 H 7 N 3 O 2 , NASC), N-acryloyl One or more of glycinamide (C 5 H 8 N 2 O 2 , NAGA), allyl urea and allyl urea;
- the solvents include water and dimethylsulfoxide.
- the raw materials used in the present invention are preferably commercially available products.
- the invention provides photocurable hydrogel ink.
- the photocurable hydrogel ink includes the following components: monomer, photoinitiator, dye and solvent.
- the monomers include high-density hydrogen-bonding unsaturated monomers; the high-density hydrogen-bonding unsaturated monomers include N-acryloyl semicarbazide (C 4 H 7 N 3 O 2 , NASC) , N-acryloyl glycinamide (C 5 H 8 N 2 O 2 , NAGA), allyl urea and one or more of allyl urea, preferably including N-acryloyl semicarbazide or N-acryloyl Glycinamide, further preferably includes N-acryloylsemicarbazide.
- N-acryloyl semicarbazide C 4 H 7 N 3 O 2 , NASC
- N-acryloyl glycinamide C 5 H 8 N 2 O 2 , NAGA
- allyl urea preferably including N-acryloyl semicarbazide or N-acryloyl Glycinamide, further preferably includes N-acryloylsemicarbazide.
- the monomer preferably further includes a low-density hydrogen-bonding unsaturated monomer; the low-density hydrogen-bonding unsaturated monomer preferably includes acrylamide or acrylic acid.
- the mass ratio of the low-density hydrogen-bonding unsaturated monomer to the high-density hydrogen-bonding unsaturated monomer is preferably (1-5):10, more preferably (2-4):10.
- the photoinitiator is preferably a water-based photoinitiator; the water-based photoinitiator preferably includes one or more of photoinitiator 2959, photoinitiator LAP and photoinitiator V-50.
- the mass of the photoinitiator is preferably 0.1-1% of the monomer mass, preferably 0.5%.
- the dye is preferably a water-based dye, and the water-based dye preferably includes tartrazine or anthocyanin.
- the mass of the dye is preferably 0.02-0.5% of the monomer mass.
- the solvent includes water and dimethyl sulfoxide.
- the mass ratio of water and dimethyl sulfoxide in the solvent is preferably 9:1 ⁇ 1:9, more preferably 7:3.
- the mass percentage of solute in the photocurable hydrogel ink is preferably 5-30%; the solute refers to all components in the photocurable hydrogel ink except the solvent.
- the present invention performs 3D printing on the photocurable hydrogel ink according to a predetermined three-dimensional numerical model to obtain printed hydrogel.
- the parameters of the 3D printing include: the wavelength of the light source is preferably 385nm-405nm, more preferably 405nm; the exposure time of each layer is preferably 5s-60s, more preferably 20s-30s; the slice layer thickness is preferably 0.05 mm to 0.1 mm; the temperature of the printing environment is preferably room temperature, that is, neither additional cooling nor additional heating is required.
- the present invention immerses the printed hydrogel in water to obtain the structured hydrogel.
- the time of the water immersion is preferably 5-15 days, more preferably 10 days.
- the temperature of the water immersion is preferably room temperature, that is, neither additional cooling nor additional heating is required.
- the water immersion refers to soaking the printed hydrogel in water for phase inversion.
- Figure 1 is a schematic diagram of the preparation of the structured functional hydrogel provided by the present invention.
- the present invention also provides a method for preparing a hydrogel heart and a valve, comprising the following steps:
- the photocurable hydrogel ink is subjected to photocurable 3D printing to obtain the printed hydrogel;
- the photocurable hydrogel ink includes the following: monomers, RAFT reagents, photoinitiators, dyes and solvents;
- the monomers include high-density hydrogen-bonding unsaturated monomers, and the high-density hydrogen-bonding unsaturated monomers include N-acryloyl semicarbazide (C 4 H 7 N 3 O 2 , NASC), N-acryloyl One or more of glycinamide (C 5 H 8 N 2 O 2 , NAGA), allyl urea and allyl urea;
- the solvent includes water and dimethyl sulfoxide
- the functional monomers include sodium styrene sulfonate or heparan-like active monomers.
- the invention provides photocurable hydrogel ink.
- the photocurable hydrogel ink includes the following: monomer, RAFT reagent, photoinitiator, dye and solvent.
- the monomers include high-density hydrogen-bonding unsaturated monomers; the high-density hydrogen-bonding unsaturated monomers include N-acryloyl semicarbazide (C 4 H 7 N 3 O 2 , NASC) , N-acryloyl glycinamide (C 5 H 8 N 2 O 2 , NAGA), allyl urea and one or more of allyl urea, preferably including N-acryloyl semicarbazide or N-acryloyl Glycinamide, further preferably includes N-acryloylsemicarbazide.
- N-acryloyl semicarbazide C 4 H 7 N 3 O 2 , NASC
- N-acryloyl glycinamide C 5 H 8 N 2 O 2 , NAGA
- allyl urea preferably including N-acryloyl semicarbazide or N-acryloyl Glycinamide, further preferably includes N-acryloylsemicarbazide.
- the monomer preferably further includes a low-density hydrogen-bonding unsaturated monomer; the low-density hydrogen-bonding unsaturated monomer preferably includes acrylamide or acrylic acid.
- the mass ratio of the low-density hydrogen-bonding unsaturated monomer to the high-density hydrogen-bonding unsaturated monomer is preferably (1-5):10, more preferably (2-4):10.
- the RAFT agent is preferably a water-soluble RAFT agent; the water-soluble RAFT agent preferably includes 4-cyano-4-(((ethylthio)thiocarbonyl)thio)pentanoic acid, 2- (n-Butylthiocarbonylthio)propionic acid or 4-cyano-4-((dodecylsulfanylthiocarbonyl)sulfanyl)pentanoic acid.
- the mass of the RAFT agent is preferably 0.1-2% of the monomer mass.
- the photoinitiator is preferably a water-based photoinitiator; the water-based photoinitiator preferably includes one or more of photoinitiator 2959, photoinitiator LAP and photoinitiator V-50.
- the mass of the photoinitiator is preferably 0.1-1% of the monomer mass, more preferably 0.5%.
- the dye is preferably a water-based dye; the water-based dye preferably includes tartrazine, eosin or anthocyanin.
- the mass of the dye is preferably 0.02-0.5% of the monomer mass.
- the solvent includes water and dimethyl sulfoxide.
- the mass ratio of water and dimethyl sulfoxide in the solvent is preferably 9:1 ⁇ 1:9, more preferably 7:3.
- the mass percentage of solute in the photocurable hydrogel ink is preferably 5-40%; the solute refers to all components in the photocurable hydrogel ink except the solvent.
- the present invention performs photocurable 3D printing on the photocurable hydrogel ink according to the predetermined three-dimensional digital model of the heart and valves to obtain printed hydrogel.
- the parameters of the photocuring 3D printing include: the wavelength of the light source is preferably 385nm-405nm, more preferably 405nm; the exposure time of each layer is preferably 5s-60s, more preferably 20s-30s; the slice layer thickness is preferably 0.05 mm to 0.1 mm; the temperature of the printing environment is preferably room temperature, that is, neither additional cooling nor additional heating is required.
- the present invention immerses the printed hydrogel in water to obtain a structured hydrogel.
- the time of the water immersion is preferably 5-15 days.
- the temperature of the water immersion is preferably room temperature, that is, neither additional cooling nor additional heating is required.
- the water immersion refers to soaking the printed hydrogel in water for phase inversion.
- the structured hydrogel is mixed with functional monomers for surface modification to obtain the hydrogel heart and valves;
- the functional monomers include sodium styrene sulfonate or Heparin-type active monomer.
- the functional monomers include sodium styrene sulfonate or heparan-like active monomers.
- the functional monomer is preferably used in the form of a functional monomer solution
- the solvent of the functional monomer solution is preferably a polar solvent
- the polar solvent preferably includes water, N,N-dimethyl Formamide, N,N-dimethylacetamide or tetrahydrofuran; the mass concentration of the functional monomer solution is preferably 5-80%.
- the temperature of the surface modification is preferably 60-90°C, more preferably 70-80°C; the time of the surface modification is preferably 5min-48h.
- the present invention preferably further includes placing the obtained surface modification system in water for equilibrium to obtain the hydrogel heart and valve.
- the equilibrium temperature is preferably room temperature, that is, neither additional heating nor cooling is required.
- the equilibrium time is preferably 12h-72h.
- the printer light source is 405nm
- the exposure time of each layer is 20-30s
- the slice layer thickness is 0.1mm
- the temperature of the printing environment is room temperature;
- the modeling software establishes the model and imports it into the 3D printing software to drive the printer to manufacture.
- the printed hydrogel was soaked in deionized water for 10 days to obtain a structured hydrogel.
- the optical photo of the obtained structured hydrogel is shown in FIG. 2 .
- FIG. 3 A universal material testing machine was used to test the mechanical properties of the structured hydrogel, and the test results are shown in FIG. 3 . It can be seen from Figure 3 that when the strain is 70 ⁇ 53%, the tensile strength of the structured hydrogel reaches 4.43 ⁇ 0.74MPa, and the elastic modulus calculated from the stress-strain curve is 62.61 ⁇ 12.87MPa. The tear energy is 21.35 ⁇ 0.24kJ/m 2 .
- Example 1 The difference from Example 1 is: adding 10.000 g of N-acryloyl semicarbazide and 5.000 g of acrylamide.
- the test results are shown in Figure 4, as can be seen from Figure 4, when the strain is 335 ⁇ 63%, the tensile strength of the structured hydrogel The strength reaches 2.51 ⁇ 0.32MPa, the elastic modulus calculated from the stress-strain curve is 2.90 ⁇ 0.14MPa, and the tear energy of the structured hydrogel is 17.25 ⁇ 0.37kJ/m 2 .
- FIGS. 5 and 6 A universal material testing machine was used to test the mechanical properties of the structured hydrogel, and the test results are shown in FIGS. 5 and 6 . It can be seen from Figure 5 that when the strain is 410 ⁇ 34%, the tensile strength of the structured hydrogel reaches 2.06 ⁇ 0.20MPa, and the elastic modulus calculated from the stress-strain curve is 1.06 ⁇ 0.13MPa. It can be seen from Fig. 6 that the tear energy of the obtained structured hydrogel is 19.55 ⁇ 0.51 kJ/m 2 .
- the mechanical properties of the structured hydrogel are tested.
- the strain is 557 ⁇ 31%
- the tensile strength of the structured hydrogel reaches 3.25 ⁇ 0.37MPa, which is calculated from the stress-strain curve
- the elastic modulus is 1.93 ⁇ 0.22MPa
- the tear energy of the structured hydrogel is 26.35 ⁇ 0.27kJ/m 2 .
- the mechanical properties of the structured hydrogel were tested using a universal material testing machine, and the test results are shown in FIG. 8 . It can be seen from Figure 8 that when the strain is 572 ⁇ 55%, the tensile strength of the structured hydrogel reaches 7.24 ⁇ 0.47MPa, and the elastic modulus calculated from the stress-strain curve is 0.92MPa, and the tearing of the structured hydrogel Energy is 171.10 ⁇ 34kJ/m 2 .
- Example 5 The difference from Example 5 is: adding 9.615g of N-acryloylglycylamide and 2.885g of N-acryloylglycylamide.
- the mechanical properties of the structured hydrogel were tested using a universal material testing machine. When the strain was 407 ⁇ 28%, the tensile strength of the structured hydrogel reached 1.82 ⁇ 0.23MPa, which was calculated from the stress-strain curve The elastic modulus is 0.65MPa, and the tear energy of the structured hydrogel is 18.45 ⁇ 0.46kJ/m 2 .
- Example 1 The N-acryloyl semicarbazide in Example 1 was replaced with acrylamide.
- the mechanical properties of the structured hydrogel were tested using a universal material testing machine, and the test results are shown in FIG. 9 . It can be seen from Figure 9 that when the strain is 124 ⁇ 31%, the tensile strength of the structured hydrogel reaches 2.51 ⁇ 0.02kPa; the elastic modulus calculated from the stress-strain curve is 3.87 ⁇ 1.5kPa; The tear energy is 0.45 ⁇ 0.03kJ/m 2 .
- the mechanical properties of the structured hydrogel are tested.
- the strain is 212 ⁇ 34%
- the tensile strength of the structured hydrogel reaches 0.77 ⁇ 0.11MPa; calculated from the stress-strain curve
- the elastic modulus is 0.34 ⁇ 0.02MPa; the tear energy of the structured hydrogel is 3.27 ⁇ 0.26kJ/m 2 .
- Example 1 The difference from Example 1 is that water immersion is not carried out.
- the mechanical properties of the printed hydrogel were tested using a universal material testing machine. When the strain was 277 ⁇ 28%, the tensile strength of the printed hydrogel reached 0.67 ⁇ 0.08MPa; the elastic modulus was calculated from the stress-strain curve The amount is 0.39 ⁇ 0.21MPa, and the tear energy of the printed hydrogel is 2.77 ⁇ 0.31kJ/m 2 .
- the printer light source is 405nm
- the exposure time of each layer is 20-30s
- the slice layer thickness is 0.1mm
- the temperature of the printing environment is room temperature
- the modeling software establishes the heart valve model, and imports the 3D printing software to drive the printer to manufacture. Soaking the 3D printed valve structural hydrogel with deionized water for 10 days to obtain a structured hydrogel heart valve;
- the surface-functionalized hydrogel heart valve was soaked in deionized water for 24 hours, and the N,N-dimethylformamide solvent was removed to obtain the hydrogel heart valve (the specific structure is shown in FIG. 10 ).
- the preparation process refers to Example 7, the only difference is that the tubular hydrogel heart valve and the heart are prepared, and the actual pictures are shown in Fig. 12 and Fig. 13 .
- Example 7 The difference from Example 7 is: no acrylamide is added.
- Example 7 The difference from Example 7 is that N-acryloylsemicarbazide is replaced by N-acryloyl glycinamide.
- the physical picture is shown in Figure 16.
- the mechanical properties of the hydrogel heart valve are tested.
- the strain is 319 ⁇ 12%
- the tensile strength of the hydrogel heart valve reaches 0.55 ⁇ 0.06MPa; calculated from the stress-strain curve
- the elastic modulus is 0.13 ⁇ 0.09MPa
- the tear energy of the hydrogel heart valve is 3.55 ⁇ 0.43kJ/m 2 .
- Example 7 The difference from Example 7 is that no surface modification is performed.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Mechanical Engineering (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Structural Engineering (AREA)
- Composite Materials (AREA)
- Civil Engineering (AREA)
- Ceramic Engineering (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polymerisation Methods In General (AREA)
Abstract
本发明属于水凝胶技术领域,提供了一种结构化水凝胶和水凝胶心脏及瓣膜的制备方法。本发明的制备方法包括:提供光固化水凝胶墨水;建立三维数模型,对所述光固化水凝胶墨水进行光固化3D打印,得到打印水凝胶;将所述打印水凝胶进行水浸,得到所述结构化功能水凝胶;所述光固化水凝胶墨水包括:高密度氢键型不饱单体、光引发剂、染料和溶剂;所述溶剂包括水和二甲基亚砜。本发明将高密度氢键型不饱单体溶解在二甲亚砜和水的混合溶剂中配置成光固化水凝胶墨水,进行光固化3D打印后,得到的打印水凝胶进行水浸,使得打印水凝胶中的二甲亚砜扩散至水中进行相转化,从而使打印水凝胶内部的氢键重构,最终提高结构化功能水凝胶的韧性。
Description
本申请要求于2021年12月23日提交中国专利局、申请号为202111591052.7、发明名称为“一种结构化水凝胶和水凝胶心脏及瓣膜的制备方法”的中国专利申请的优先权,其全部内容通过引用结合在本申请中。
本发明涉及水凝胶技术领域,尤其涉及结构化水凝胶和水凝胶心脏及瓣膜的制备方法。
近年来,新型生物材料如聚合物、陶瓷和金属等生物材料取得了快速的发展,已在医疗领域广泛应用,大大提高了众多疾病的治疗效率。尽管生物材料在生物医学上的应用非常广泛,但是由于许多生物材料缺乏理想的功能特性(例如生物体力学匹配度、生物相容性、个性化生物制造以及生物***的表界面相互作用),使其仍然应用受限。
基于生物材料的现状和未来的发展,需要对新型生物材料的设计、合成、功能和结构化制造进行控制,由此产生了以水凝胶为基础的新型生物材料。水凝胶具有亲水性聚合物网络结构,水可以渗透到亲水性聚合物网络结构的聚合物链之间,从而导致溶胀。水凝胶在生物应用方面的优势在于其高的水分含量、生物力学匹配性和生物相容性。传统的水凝胶通常分成天然水凝胶和合成水凝胶两大类。天然水凝胶包括多糖类(如纤维素、海藻酸、透明质酸,壳聚糖等)和多肽类(如聚L-赖氨酸、胶原、聚L-谷胺酸等)。合成水凝胶包括醇、丙烯酸及其衍生物类(如聚丙烯酸,聚甲基丙烯酸,聚丙烯酰胺等)。
现有的水凝胶,不论是天然水凝胶还是合成水凝胶韧性差。
发明内容
有鉴于此,本发明的目的在于提供一种结构化水凝胶和水凝胶心脏及 瓣膜的制备方法。本发明提供的制备方法得到的结构化水凝胶具有优异的韧性。
为了实现上述发明目的,本发明提供以下技术方案:
本发明提供了一种结构化水凝胶的制备方法,包括以下步骤:
提供光固化水凝胶墨水;
按照预定的三维数模型,对所述光固化水凝胶墨水进行光固化3D打印,得到打印水凝胶;
将所述打印水凝胶进行水浸,得到所述结构化水凝胶;
所述光固化水凝胶墨水包括以下组分:单体、光引发剂、染料和溶剂;
所述单体包括高密度氢键型不饱单体,所述高密度氢键型不饱单体包括N-丙烯酰基氨基脲、N-丙烯酰甘氨酰胺、烯丙基脲和丙烯基脲中的一种或多种;
所述溶剂包括水和二甲基亚砜。
优选地,所述单体还包括低密度氢键型不饱单体,所述低密度氢键型不饱单体包括丙烯酰胺或丙烯酸。
优选地,所述溶剂中水和二甲基亚砜的质量比为9:1~1:9。
优选地,所述光引发剂为水性光引发剂;所述水性光引发剂包括2959光引发剂、LAP光引发剂和V-50光引发剂中的一种或多种;所述光引发剂的质量为单体质量的0.1~1%。
优选地,所述光固化水凝胶墨水中溶质的质量百分含量为5~30%。
优选地,所述光固化3D打印的参数包括:光源的波长为385nm~405nm;每层曝光时间为5s~60s;切片层厚为0.05mm~0.1mm。
优选地,所述水浸的时间为5~15天。
本发明还提供了一种水凝胶心脏及瓣膜的制备方法,包括以下步骤:
提供光固化水凝胶墨水;
按照预定的心脏及瓣膜的三维数模型,对所述光固化水凝胶墨水进行光固化3D打印,得到打印水凝胶;
将所述打印水凝胶进行水浸,得到结构化水凝胶;
将所述结构化水凝胶和功能单体混合,进行表面改性,得到所述水凝 胶心脏及瓣膜;
所述光固化水凝胶墨水包括以下组分:单体、RAFT试剂、光引发剂、染料和溶剂;
所述单体包括高密度氢键型不饱单体,所述高密度氢键型不饱单体包括N-丙烯酰基氨基脲、N-丙烯酰甘氨酰胺、烯丙基脲和丙烯基脲中的一种或多种;
所述溶剂包括水和二甲基亚砜;
所述功能单体包括苯乙烯磺酸钠或类肝素型活性单体。
优选地,所述RAFT试剂为水溶性RAFT试剂;所述水溶性RAFT试剂包括4-氰基-4-(((乙硫基)硫代羰基)硫基)戊酸、2-(正丁基硫代碳硫酰硫基)丙酸或4-氰基-4-((十二烷基硫烷基硫羰基)硫烷基)戊酸;所述RAFT试剂的质量为单体质量的0.1~2%。
优选地,所述表面改性的温度为60~90℃,时间为5min~48h。
本发明提供了一种结构化水凝胶的制备方法,包括以下步骤:提供光固化水凝胶墨水;按照预定的三维数模型,对所述光固化水凝胶墨水进行光固化3D打印,得到打印水凝胶;将所述打印水凝胶进行水浸,得到所述结构化水凝胶;所述光固化水凝胶墨水包括以下组分:单体、光引发剂、染料和溶剂;所述单体包括高密度氢键型不饱单体,所述高密度氢键型不饱单体包括N-丙烯酰基氨基脲、N-丙烯酰甘氨酰胺、烯丙基脲和丙烯基脲中的一种或多种;所述溶剂包括水和二甲基亚砜。本发明将高密度氢键型不饱单体溶解在二甲亚砜和水的混合溶剂中配置成光固化水凝胶墨水,进行光固化3D打印后,得到的打印水凝胶进行水浸,使得打印水凝胶中的二甲亚砜扩散至水中进行相转化,从而使打印水凝胶内部的氢键重构,最终提高结构化功能水凝胶的韧性。
本发明还提供了一种水凝胶心脏及瓣膜的制备方法,包括以下步骤:提供光固化水凝胶墨水;按照预定的心脏及瓣膜的三维数模型,对所述光固化水凝胶墨水进行光固化3D打印,得到打印水凝胶;将所述打印水凝胶进行水浸,得到结构化水凝胶;将所述结构化水凝胶和功能单体混合,进行表面改性,得到所述水凝胶心脏及瓣膜;所述光固化水凝胶墨水包括 以下组分:单体、RAFT试剂、光引发剂、染料和溶剂;所述单体包括高密度氢键型不饱单体,所述高密度氢键型不饱单体包括N-丙烯酰基氨基脲、N-丙烯酰甘氨酰胺、烯丙基脲和丙烯基脲中的一种或多种;所述溶剂包括水和二甲基亚砜;所述功能单体包括苯乙烯磺酸钠或类肝素型活性单体。本发明将高密度氢键型不饱单体溶解在二甲亚砜和水的混合溶剂中配置成光固化水凝胶墨水,进行光固化3D打印后,得到的打印水凝胶进行水浸,使得打印水凝胶中的二甲亚砜扩散至水中进行相转化,从而使打印水凝胶内部的氢键重构,最终提高结构化功能水凝胶的韧性。再利用苯乙烯磺酸钠或类肝素型活性单体对结构化水凝胶进行表面改性,能够提高水凝胶心脏及瓣膜的细胞相容性、血液相容性以及组织相容性。
图1为本发明提供的结构化水凝胶的制备原理图;
图2为实施例1制备得到的结构化水凝胶的光学照片;
图3为实施例1制备得到的结构化水凝胶的力学性能图;
图4为实施例2制备得到的结构化水凝胶的力学性能图;
图5为实施例3制备得到的结构化水凝胶的力学性能图;
图6为实施例3制备得到的结构化水凝胶的力学性能图;
图7为实施例5制备得到的结构化水凝胶的光学照片;
图8为实施例5制备得到的结构化水凝胶的力学性能图;
图9为对比例1制备得到的结构化水凝胶的力学性能图;
图10为实施例7制备得到的水凝胶心脏瓣膜的光学照片;
图11为实施例7制备得到的水凝胶心脏瓣膜的力学性能图;
图12为实施例8制备得到的管状水凝胶心脏瓣膜的光学照片;
图13为实施例8制备得到的心脏的光学照片;
图14为实施例9制备得到的水凝胶心脏瓣膜的力学性能图;
图15为实施例10制备得到的水凝胶心脏瓣膜的力学性能图;
图16为实施例11制备得到的水凝胶心脏瓣膜的光学照片;
图17为对比例4制备得到的水凝胶心脏瓣膜的力学性能图;
图18为对比例5制备得到的水凝胶心脏瓣膜的力学性能图。
本发明提供了一种结构化功能水凝胶的制备方法,包括以下步骤:
提供光固化水凝胶墨水;
按照预定的三维数模型,对所述光固化水凝胶墨水进行光固化3D打印,得到打印水凝胶;
将所述打印水凝胶进行水浸,得到所述结构化功能水凝胶;
所述光固化水凝胶墨水包括以下组分:单体、光引发剂、染料和溶剂;
所述单体包括高密度氢键型不饱单体,所述高密度氢键型不饱单体包括N-丙烯酰基氨基脲(C
4H
7N
3O
2,NASC)、N-丙烯酰甘氨酰胺(C
5H
8N
2O
2,NAGA)、烯丙基脲和丙烯基脲中的一种或多种;
所述溶剂包括水和二甲基亚砜。
在本发明中,如无特殊说明,本发明所用原料均优选为市售产品。
本发明提供光固化水凝胶墨水。
在本发明中,所述光固化水凝胶墨水包括以下组分:单体、光引发剂、染料和溶剂。
在本发明中,所述单体包括高密度氢键型不饱单体;所述高密度氢键型不饱单体包括N-丙烯酰基氨基脲(C
4H
7N
3O
2,NASC)、N-丙烯酰甘氨酰胺(C
5H
8N
2O
2,NAGA)、烯丙基脲和丙烯基脲中的一种或多种,优选包括N-丙烯酰基氨基脲或N-丙烯酰甘氨酰胺,进一步优选包括N-丙烯酰基氨基脲。
在本发明中,所述单体优选还包括低密度氢键型不饱单体;所述低密度氢键型不饱单体优选包括丙烯酰胺或丙烯酸。在本发明中,所述低密度氢键型不饱单体和高密度氢键型不饱单体的质量比优选为(1~5):10,进一步优选为(2~4):10。
在本发明中,所述光引发剂优选为水性光引发剂;所述水性光引发剂优选包括光引发剂2959、光引发剂LAP和光引发剂V-50中的一种或多种。在本发明中,所述光引发剂的质量优选为单体质量的0.1~1%,优选为0.5%。
在本发明中,所述染料优选为水性染料,所述水性染料优选包括柠檬 黄或花青素。在本发明中,所述染料的质量优选为单体质量的0.02~0.5%。
在本发明中,所述溶剂包括水和二甲基亚砜。在本发明中,所述溶剂中水和二甲基亚砜的质量比优选为9:1~1:9,进一步优选为7:3。
在本发明中,所述光固化水凝胶墨水中溶质的质量百分含量优选为5~30%;所述溶质是指光固化水凝胶墨水中除溶剂之外的所有组分。
提供光固化水凝胶墨水后,本发明按照预定的三维数模型,对所述光固化水凝胶墨水进行3D打印,得到打印水凝胶。
在本发明中,所述3D打印的参数包括:光源的波长优选为385nm~405nm,进一步优选为405nm;每层曝光时间优选为5s~60s,进一步优选为20s~30s;切片层厚优选为0.05mm~0.1mm;打印环境的温度优选为室温,即既不需要额外降温也不需要额外加热。
得到打印水凝胶后,本发明将所述打印水凝胶进行水浸,得到所述结构化水凝胶。
在本发明中,所述水浸的时间优选为5~15天,进一步优选为10天。在本发明中,所述水浸的温度优选为室温,即既不需要额外降温也不需要额外加热。在本发明中,所述水浸是指将所述打印水凝胶浸泡在水中进行相转化。
图1为本发明提供的结构化功能水凝胶的制备原理图。
本发明还提供了一种水凝胶心脏及瓣膜的制备方法,包括以下步骤:
提供光固化水凝胶墨水;
按照预定的心脏及瓣膜的三维数模型,对所述光固化水凝胶墨水进行光固化3D打印,得到打印水凝胶;
将所述打印水凝胶进行水浸,得到结构化水凝胶;
将所述结构化水凝胶和功能单体混合,进行表面改性,得到水凝胶心脏及瓣膜;
所述光固化水凝胶墨水包括以下:单体、RAFT试剂、光引发剂、染料和溶剂;
所述单体包括高密度氢键型不饱单体,所述高密度氢键型不饱单体包括N-丙烯酰基氨基脲(C
4H
7N
3O
2,NASC)、N-丙烯酰甘氨酰胺(C
5H
8N
2O
2, NAGA)、烯丙基脲和丙烯基脲中的一种或多种;
所述溶剂包括水和二甲基亚砜;
所述功能单体包括苯乙烯磺酸钠或类肝素型活性单体。
本发明提供光固化水凝胶墨水。
在本发明中,所述光固化水凝胶墨水包括以下:单体、RAFT试剂、光引发剂、染料和溶剂。
在本发明中,所述单体包括高密度氢键型不饱单体;所述高密度氢键型不饱单体包括N-丙烯酰基氨基脲(C
4H
7N
3O
2,NASC)、N-丙烯酰甘氨酰胺(C
5H
8N
2O
2,NAGA)、烯丙基脲和丙烯基脲中的一种或多种,优选包括N-丙烯酰基氨基脲或N-丙烯酰甘氨酰胺,进一步优选包括N-丙烯酰基氨基脲。
在本发明中,所述单体优选还包括低密度氢键型不饱单体;所述低密度氢键型不饱单体优选包括丙烯酰胺或丙烯酸。在本发明中,所述低密度氢键型不饱单体和高密度氢键型不饱单体的质量比优选为(1~5):10,进一步优选为(2~4):10。
在本发明中,所述RAFT试剂优选为水溶性RAFT试剂;所述水溶性RAFT试剂优选包括4-氰基-4-(((乙硫基)硫代羰基)硫基)戊酸、2-(正丁基硫代碳硫酰硫基)丙酸或4-氰基-4-((十二烷基硫烷基硫羰基)硫烷基)戊酸。在本发明中,所述RAFT试剂的质量优选为单体质量的0.1~2%。
在本发明中,所述光引发剂优选为水性光引发剂;所述水性光引发剂优选包括光引发剂2959、光引发剂LAP和光引发剂V-50中的一种或多种。在本发明中,所述光引发剂的质量优选为单体质量的0.1~1%,进一步优选为0.5%。
在本发明中,所述染料优选为水性染料;所述水性染料优选包括柠檬黄、曙红或花青素。在本发明中,所述染料的质量优选为单体质量的0.02~0.5%。
在本发明中,所述溶剂包括水和二甲基亚砜。在本发明中,所述溶剂中水和二甲基亚砜的质量比优选为9:1~1:9,进一步优选为7:3。
在本发明中,所述光固化水凝胶墨水中溶质的质量百分含量优选为 5~40%;所述溶质是指光固化水凝胶墨水中除溶剂之外的所有组分。
提供光固化水凝胶墨水后,本发明建按照预定的心脏及瓣膜的三维数模型,对所述光固化水凝胶墨水进行光固化3D打印,得到打印水凝胶。
在本发明中,所述光固化3D打印的参数包括:光源的波长优选为385nm~405nm,进一步优选为405nm;每层曝光时间优选为5s~60s,进一步优选为20s~30s;切片层厚优选为0.05mm~0.1mm;打印环境的温度优选为室温,即既不需要额外降温也不需要额外加热。
得到打印水凝胶后,本发明将所述打印水凝胶进行水浸,得到结构化水凝胶。
在本发明中,所述水浸的时间优选为5~15天。在本发明中,所述水浸的温度优选为室温,即既不需要额外降温也不需要额外加热。在本发明中,所述水浸是指将所述打印水凝胶浸泡在水中进行相转化。
得到结构化水凝胶后,将所述结构化水凝胶和功能单体混合,进行表面改性,得到所述水凝胶心脏及瓣膜;所述功能单体包括苯乙烯磺酸钠或类肝素型活性单体。
在本发明中,所述功能单体包括苯乙烯磺酸钠或类肝素型活性单体。
在本发明中,所述功能单体优选以功能单体溶液的形式使用,所述功能单体溶液的溶剂优选为极性溶剂,所述极性溶剂优选包括水、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺或四氢呋喃;所述功能单体溶液的质量浓度优选为5~80%。
在本发明中,所述表面改性的温度优选为60~90℃,进一步优选为70~80℃;所述表面改性的时间优选为5min~48h。
所述表面改性后,本发明优选还包括将得到的表面改性体系置于水中,进行平衡,得到所述水凝胶心脏及瓣膜。
在本发明中,所述平衡的温度优选为室温,即既不需要额外加热也不需要额外降温。在本发明中,所述平衡的时间优选为12h~72h。
下面结合实施例对本发明提供的结构化水凝胶的制备方法及水凝胶心脏及瓣膜的制备方法进行详细的说明,但是不能把它们理解为对本发明保护范围的限定。
实施例1
将15.000g的N-丙烯酰基氨基脲加入到35.000g的二甲亚砜和去离子水的混合溶剂中(二甲亚砜和去离子水质量比为7:3),单体完全溶解后加入0.075g光引发剂(LAP)(单体质量的0.5%),加入0.010g柠檬黄,最终得到均匀透明的光固化水凝胶墨水。
将所述光固化水凝胶墨水转移至光固化3D打印机的料盒中,打印机光源为405nm,每层曝光时间为20~30s,切片层厚为0.1mm,打印环境的温度为室温;利用三维建模软件建立模型,并导入3D打印软件驱动打印机制造。将所述打印的水凝胶用去离子水进行浸泡10天,得到结构化水凝胶,所得结构化水凝胶的光学照片如图2所示。
利用万能材料试验机,对所述结构化水凝胶的力学性能进行测试,测试结果如图3所示。由图3可知:在应变为70±53%时,结构化水凝胶的拉伸强度达到4.43±0.74MPa,由应力应变曲线计算得到弹性模量为62.61±12.87MPa,结构化水凝胶的撕裂能为21.35±0.24kJ/m
2。
实施例2
与实施例1的区别为:加入10.000g的N-丙烯酰基氨基脲和5.000g丙烯酰胺。利用万能材料试验机,对所述结构化水凝胶的力学性能进行测试,测试结果如图4所示,由图4可知,在应变为335±63%时,结构化水凝胶的拉伸强度达到2.51±0.32MPa,由应力应变曲线计算得到弹性模量为2.90±0.14MPa,结构化水凝胶的撕裂能为17.25±0.37kJ/m
2。
实施例3
将8.330g的N-丙烯酰基氨基脲和4.170g丙烯酰胺加入到37.500g的二甲亚砜和去离子水的混合溶剂中(二甲亚砜和去离子水质量比为7:3),使单体完全溶解后加入0.063g引发剂(LAP)(单体质量的0.5%),加入0.01g柠檬黄,最终得到均匀透明的光固化水凝胶墨水。
打印和后处理同实施例1。
利用万能材料试验机,对所述结构化水凝胶的力学性能进行测试,测试结果如图5和图6所示。由图5可知:在应变为410±34%时,结构化水凝胶的拉伸强度达到2.06±0.20MPa,由应力应变曲线计算得到弹性模 量为1.06±0.13MPa。由图6可知,所得结构化水凝胶的撕裂能为19.55±0.51kJ/m
2。
实施例4
将10.000g的N-丙烯酰基氨基脲和2.500g丙烯酰胺加入到37.500g的二甲亚砜和去离子水的混合溶剂中(二甲亚砜和去离子水质量比为7:3),使单质完全溶解后加入0.063g引发剂(LAP)(单体质量的0.5%),加入0.010g柠檬黄,最终得到均匀透明的光固化水凝胶墨水。
打印和后处理同实施例1。
利用万能材料试验机,对所述结构化水凝胶的力学性能进行测试,在应变为557±31%时,结构化水凝胶的拉伸强度达到3.25±0.37MPa,由应力应变曲线计算得到弹性模量为1.93±0.22MPa,结构化水凝胶的撕裂能为26.35±0.27kJ/m
2。
实施例5
将9.615g的N-丙烯酰基氨基脲和2.885g丙烯酸加入到37.500g的二甲亚砜和去离子水的混合溶剂中(二甲亚砜和去离子水质量比为7:3),使单质完全溶解后加入0.063g引发剂(LAP)(单体质量的0.5%),加入0.010g柠檬黄,得到均匀透明的光固化水凝胶墨水。所得结构化功能水凝胶的光学照片如图7所示。
利用万能材料试验机,对所述结构化水凝胶的力学性能进行测试,测试结果如图8所示。由图8可知:在应变为572±55%时,结构化水凝胶的拉伸强度达到7.24±0.47MPa,由应力应变曲线计算得到弹性模量为0.92MPa,结构化水凝胶的撕裂能为171.10±34kJ/m
2。
实施例6
与实施例5的区别为:加入9.615g的N-丙烯酰甘氨酰胺和2.885g的N-丙烯酰甘氨酰胺。
打印和后处理同实施例1。
利用万能材料试验机,对所述结构化水凝胶的力学性能进行测试,在应变为407±28%时,结构化水凝胶的拉伸强度达到1.82±0.23MPa,由应 力应变曲线计算得到弹性模量为0.65MPa,结构化水凝胶的撕裂能为18.45±0.46kJ/m
2。
对比例1
将实施例1中的N-丙烯酰基氨基脲替换为丙烯酰胺。
利用万能材料试验机,对所述结构化水凝胶的力学性能进行测试,测试结果如图9所示。由图9可知:在应变为124±31%时,结构化水凝胶的拉伸强度达到2.51±0.02kPa;由应力应变曲线计算得到弹性模量为3.87±1.5kPa;结构化水凝胶的撕裂能为0.45±0.03kJ/m
2。
对比例2
省略实施例1中的二甲基亚砜。
利用万能材料试验机,对所述结构化水凝胶的力学性能进行测试,在应变为212±34%时,结构化水凝胶的拉伸强度达到0.77±0.11MPa;由应力应变曲线计算得到弹性模量为0.34±0.02MPa;结构化水凝胶的撕裂能为3.27±0.26kJ/m
2。
对比例3
与实施例1的区别为不进行水浸。
利用万能材料试验机,对得到的打印水凝胶的力学性能进行测试,在应变为277±28%时,打印水凝胶的拉伸强度达到0.67±0.08MPa;由应力应变曲线计算得到弹性模量为0.39±0.21MPa,打印水凝胶的撕裂能为2.77±0.31kJ/m
2。
实施例7
将8.3300g的N-丙烯酰基氨基脲和4.1700g丙烯酰胺加入到37.5000g的二甲亚砜和去离子水的混合溶剂中(二甲亚砜和水的质量比为7:3),使单体完全溶解后加入0.0625g引发剂(LAP)(单体质量的0.5%),加入0.0125g RAFT试剂(4-氰基-4-(((乙硫基)硫代羰基)硫基)戊酸)(单体质量的0.1%),加入0.0100g柠檬黄,最终得到均匀透明的光固化水凝胶墨水。
将所述光固化水凝胶墨水转移至光固化3D打印机的料盒中,打印机光源为405nm,每层曝光时间为20~30s,切片层厚为0.1mm,打印环 境的温度为室温;利用三维建模软件建立心脏瓣膜模型,并导入3D打印软件驱动打印机制造。将所述3D打印的瓣膜结构水凝胶用去离子水进行浸泡10天,得到结构化水凝胶心脏瓣膜;
将所述结构化水凝胶心脏瓣膜浸润到对苯乙烯磺酸钠单体溶液(其中对苯乙烯磺酸钠10g,溶剂为90mL的N,N-二甲基甲酰胺)中进行表面改性,在氮气保护下60℃反应1小时;
将所述表面功能化的水凝胶心脏瓣膜浸润到去离子水中24h,去除N,N-二甲基甲酰胺溶剂,得到所述水凝胶心脏瓣膜(具体结构如图10所示)。
利用万能材料试验机,对所述水凝胶心脏瓣膜的力学性能进行测试,测试结果如图11所示,由图11可知,在应变为475%±82时,水凝胶心脏瓣膜的拉伸强度达到1.83±0.17MPa,由应力应变曲线计算得到弹性模量为0.64±0.09MPa,水凝胶心脏瓣膜的撕裂能为15.77±0.31kJ/m
2。
实施例8
制备过程参考实施例7,区别仅在于,制备得到管状水凝胶心脏瓣膜及心脏,实物图如图12及图13所示。
实施例9
将9.3750g的N-丙烯酰基氨基脲和3.125g丙烯酰胺加入到37.5000g的二甲亚砜和去离子水的混合溶剂中(二甲亚砜和水的质量比为7:3),使单体完全溶解后加入0.0625g引发剂(LAP)(单体质量的0.5%),加入0.0125g RAFT试剂(4-氰基-4-(((乙硫基)硫代羰基)硫基)戊酸)(单体质量的0.1%),加入0.0100g柠檬黄,最终得到均匀透明的光固化水凝胶墨水。
打印和后处理同实施例7。
利用万能材料试验机,对所述水凝胶心脏瓣膜的力学性能进行测试,测试结果如图14所示,由图14可知,在应变为405±34%时,拉伸强度达到2.42±0.82MPa,由应力应变曲线计算得到弹性模量为1.12±0.23MPa,水凝胶心脏瓣膜的撕裂能为23.04±0.21kJ/m
2。
实施例10
与实施例7的区别为:不加入丙烯酰胺。
利用万能材料试验机,对所述水凝胶心脏瓣膜的力学性能进行测试,测试结果如图15所示,由图15可知,在应变为83±25%时,拉伸强度达到2.50±0.28MPa,由应力应变曲线计算得到弹性模量为33.40±5.79MPa。水凝胶心脏瓣膜的撕裂能为15.28±0.17kJ/m
2。
实施例11
与实施例7的区别为:将N-丙烯酰基氨基脲为N-丙烯酰甘氨酰胺。实物图如图16所示。
利用万能材料试验机,对所述水凝胶心脏瓣膜的力学性能进行测试,在应变为319±12%时,水凝胶心脏瓣膜的拉伸强度达到0.55±0.06MPa;由应力应变曲线计算得到弹性模量为0.13±0.09MPa,水凝胶心脏瓣膜的撕裂能为3.55±0.43kJ/m
2。
对比例4
将6.2500g的N-丙烯酰基氨基脲和6.2500g丙烯酰胺加入到37.5000g的二甲亚砜和去离子水的混合溶剂中(二甲亚砜和水的质量比为7:3),使单体完全溶解后加入0.0625g引发剂(LAP)(单体质量的0.5%),加入0.0125g RAFT试剂(4-氰基-4-(((乙硫基)硫代羰基)硫基)戊酸)(单体质量的0.1%),加入0.0100g柠檬黄,最终得到均匀透明的光固化水凝胶墨水。
打印和后处理同实施例7。
利用万能材料试验机,对所述水凝胶心脏瓣膜的力学性能进行测试,测试结果如图17所示,由图17可知,在应变为325%±73时,拉伸强度达到14.62±1.77kPa,由应力应变曲线计算得到弹性模量为6.11±2.15kPa。水凝胶心脏瓣膜的撕裂能为0.77±0.01kJ/m
2。
对比例5
与实施例7的区别为:不进行表面改性。
利用万能材料试验机,对所述结构化水凝胶心脏瓣膜的力学性能进行测试,测试结果如图18所示,由图18可知,在应变为442±45%时,拉伸强度达到2.26±0.10MPa,由应力应变曲线计算得到弹性模量为 1.44±0.17MPa,结构化水凝胶心脏瓣膜的撕裂能为20.87±0.66kJ/m
2。
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (16)
- 一种结构化水凝胶的制备方法,其特征在于,包括以下步骤:提供光固化水凝胶墨水;按照预定的三维数模型,对所述光固化水凝胶墨水进行光固化3D打印,得到打印水凝胶;将所述打印水凝胶进行水浸,得到所述结构化水凝胶;所述光固化水凝胶墨水包括以下组分:单体、光引发剂、染料和溶剂;所述单体包括高密度氢键型不饱单体,所述高密度氢键型不饱单体包括N-丙烯酰基氨基脲、N-丙烯酰甘氨酰胺、烯丙基脲和丙烯基脲中的一种或多种;所述溶剂包括水和二甲基亚砜。
- 根据权利要求1所述的制备方法,其特征在于,所述单体还包括低密度氢键型不饱单体,所述低密度氢键型不饱单体包括丙烯酰胺或丙烯酸。
- 根据权利要求2所述的制备方法,其特征在于,所述低密度氢键型不饱单体和高密度氢键型不饱单体的质量比为(1~5):10。
- 根据权利要求1所述的制备方法,其特征在于,所述溶剂中水和二甲基亚砜的质量比为9:1~1:9。
- 根据权利要求1所述的制备方法,其特征在于,所述光引发剂为水性光引发剂;所述水性光引发剂包括2959光引发剂、LAP光引发剂和V-50光引发剂中的一种或多种;所述光引发剂的质量为单体质量的0.1~1%。
- 根据权利要求1所述的制备方法,其特征在于,所述染料为水性染料;所述染料的质量为单体质量的0.02~0.5%。
- 根据权利要求1~6任一项所述的制备方法,其特征在于,所述光固化水凝胶墨水中溶质的质量百分含量为5~30%。
- 根据权利要求1或5所述的制备方法,其特征在于,所述光固化3D打印的参数包括:光源的波长为385~405nm;每层曝光时间为5s~60s;切片层厚为0.05mm~0.1mm。
- 根据权利要求1所述的制备方法,其特征在于,所述水浸的时间为5~15天。
- 一种水凝胶心脏及瓣膜的制备方法,其特征在于,包括以下步骤:提供光固化水凝胶墨水;按照预定的心脏及瓣膜的三维数模型,对所述光固化水凝胶墨水进行光固化3D打印,得到打印水凝胶;将所述打印水凝胶进行水浸,得到结构化水凝胶;将所述结构化水凝胶和功能单体混合,进行表面改性,得到所述水凝胶心脏及瓣膜;所述光固化水凝胶墨水包括以下组分:单体、RAFT试剂、光引发剂、染料和溶剂;所述单体包括高密度氢键型不饱单体,所述高密度氢键型不饱单体包括N-丙烯酰基氨基脲、N-丙烯酰甘氨酰胺、烯丙基脲和丙烯基脲中的一种或多种;所述溶剂包括水和二甲基亚砜;所述功能单体包括苯乙烯磺酸钠或类肝素型活性单体。
- 根据权利要求10所述的制备方法,其特征在于,所述单体还包括低密度氢键型不饱单体;所述低密度氢键型不饱单体包括丙烯酰胺或丙烯酸。
- 根据权利要求11所述的制备方法,其特征在于,所述低密度氢键型不饱单体和高密度氢键型不饱单体的质量比为(1~5):10。
- 根据权利要求10所述的制备方法,其特征在于,所述RAFT试剂为水溶性RAFT试剂;所述水溶性RAFT试剂包括4-氰基-4-(((乙硫基)硫代羰基)硫基)戊酸、2-(正丁基硫代碳硫酰硫基)丙酸或4-氰基-4-((十二烷基硫烷基硫羰基)硫烷基)戊酸;所述RAFT试剂的质量为单体质量的0.1~2%。
- 根据权利要求10所述的制备方法,其特征在于,所述功能单体以功能单体溶液的形式使用,所述功能单体溶液的溶剂为极性溶剂,所述极性溶剂包括水、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺或四氢呋喃; 所述功能单体溶液的质量浓度为5~80%。
- 根据权利要求10或14所述的制备方法,其特征在于,所述表面改性的温度为60~90℃,时间为5min~48h。
- 根据权利要求10所述的制备方法,其特征在于,所述表面改性后,还包括将得到的表面改性体系置于水中,进行平衡;所述平衡的时间为12h~72h。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111591052.7A CN114106227B (zh) | 2021-12-23 | 2021-12-23 | 一种结构化水凝胶和水凝胶心脏及瓣膜的制备方法 |
CN202111591052.7 | 2021-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023116060A1 true WO2023116060A1 (zh) | 2023-06-29 |
Family
ID=80362577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/117682 WO2023116060A1 (zh) | 2021-12-23 | 2022-09-08 | 一种结构化水凝胶和水凝胶心脏及瓣膜的制备方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20230201427A1 (zh) |
CN (1) | CN114106227B (zh) |
WO (1) | WO2023116060A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114106227B (zh) * | 2021-12-23 | 2022-09-16 | 中国科学院兰州化学物理研究所 | 一种结构化水凝胶和水凝胶心脏及瓣膜的制备方法 |
CN114716694A (zh) * | 2022-05-06 | 2022-07-08 | 南京工业大学 | 一种促血管化和抗钙化且可3d打印心脏瓣膜的水凝胶 |
CN116041884A (zh) * | 2023-01-05 | 2023-05-02 | 中国科学院兰州化学物理研究所 | 一种光固化3d打印水凝胶超材料的制备方法及应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5883211A (en) * | 1996-01-19 | 1999-03-16 | Aclara Biosciences, Inc. | Thermoreversible hydrogels comprising linear copolymers and their use in electrophoresis |
CN112521550A (zh) * | 2019-09-18 | 2021-03-19 | 天津大学 | 一种超分子共聚水凝胶及其制备方法 |
CN112521625A (zh) * | 2019-09-18 | 2021-03-19 | 天津大学 | 一种基于脲胺的高模量超分子聚合物水凝胶及其制备方法 |
CN114106227A (zh) * | 2021-12-23 | 2022-03-01 | 中国科学院兰州化学物理研究所 | 一种结构化水凝胶和水凝胶心脏及瓣膜的制备方法 |
CN114805694A (zh) * | 2021-06-08 | 2022-07-29 | 天津大学 | 一种高刚性、高强度、高韧性润滑共聚水凝胶及其制备方法和应用 |
CN115057970A (zh) * | 2022-06-29 | 2022-09-16 | 四川大学 | 一种基于离子聚集体交联的高强高韧水凝胶及其制备方法与应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107759733B (zh) * | 2016-08-23 | 2020-06-12 | 天津大学 | 基于丙烯酰基甘氨酰胺的超分子复合水凝胶在3d打印中的应用 |
CN111234268B (zh) * | 2020-04-01 | 2021-03-30 | 北京大学 | 多功能特异性生物粘合水凝胶、制备方法及其应用 |
CN112341637B (zh) * | 2020-10-16 | 2022-02-11 | 中国科学院化学研究所 | 一种高分子凝胶用组合物及其制备的凝胶与应用 |
CN113004542A (zh) * | 2021-02-22 | 2021-06-22 | 中国科学院兰州化学物理研究所 | 一种中空水凝胶及其制备方法和应用 |
-
2021
- 2021-12-23 CN CN202111591052.7A patent/CN114106227B/zh active Active
-
2022
- 2022-09-08 WO PCT/CN2022/117682 patent/WO2023116060A1/zh unknown
- 2022-11-29 US US18/070,580 patent/US20230201427A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5883211A (en) * | 1996-01-19 | 1999-03-16 | Aclara Biosciences, Inc. | Thermoreversible hydrogels comprising linear copolymers and their use in electrophoresis |
CN112521550A (zh) * | 2019-09-18 | 2021-03-19 | 天津大学 | 一种超分子共聚水凝胶及其制备方法 |
CN112521625A (zh) * | 2019-09-18 | 2021-03-19 | 天津大学 | 一种基于脲胺的高模量超分子聚合物水凝胶及其制备方法 |
CN114805694A (zh) * | 2021-06-08 | 2022-07-29 | 天津大学 | 一种高刚性、高强度、高韧性润滑共聚水凝胶及其制备方法和应用 |
CN114106227A (zh) * | 2021-12-23 | 2022-03-01 | 中国科学院兰州化学物理研究所 | 一种结构化水凝胶和水凝胶心脏及瓣膜的制备方法 |
CN115057970A (zh) * | 2022-06-29 | 2022-09-16 | 四川大学 | 一种基于离子聚集体交联的高强高韧水凝胶及其制备方法与应用 |
Non-Patent Citations (3)
Title |
---|
"Introduction to New Functional Materials", 31 October 2014, EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY PRESS CO. LTD., CN, ISBN: 978-7-5628-3449-6, article WANG, JIKUI: "Heparin", pages: 94, XP009547588 * |
FAN CHUANCHUAN, XU ZIYANG, WU TENGLING, CUI CHUNYAN, LIU YANG, LIU BO, YANG JIANHAI, LIU WENGUANG: "3D printing of lubricative stiff supramolecular polymer hydrogels for meniscus replacement", BIOMATERIALS SCIENCE, vol. 9, 1 January 2021 (2021-01-01), GB , pages 5116 - 5126, XP093075148, ISSN: 2047-4830, DOI: 10.1039/D1BM00836F * |
ZHAI XINYUN, MA YUFEI, HOU CHUNYONG, GAO FEI, ZHANG YINYU, RUAN CHANGSHUN, PAN HAOBO, LU WILLIAM WEIJIA, LIU WENGUANG: "3D-Printed High Strength Bioactive Supramolecular Polymer/Clay Nanocomposite Hydrogel Scaffold for Bone Regeneration", HHS AUTHOR MANUSCRIPTS, vol. 3, no. 6, 12 June 2017 (2017-06-12), US , pages 1109 - 1118, XP055861973, DOI: 10.1021/acsbiomaterials.7b00224 * |
Also Published As
Publication number | Publication date |
---|---|
US20230201427A1 (en) | 2023-06-29 |
CN114106227A (zh) | 2022-03-01 |
CN114106227B (zh) | 2022-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2023116060A1 (zh) | 一种结构化水凝胶和水凝胶心脏及瓣膜的制备方法 | |
Koivisto et al. | Mechanically biomimetic gelatin–gellan gum hydrogels for 3D culture of beating human cardiomyocytes | |
CN107118359B (zh) | 光固化水凝胶及其制备方法 | |
JP4907824B2 (ja) | ヒドロゲル | |
CN106310380B (zh) | 一种纳米纤维化丝素蛋白凝胶及其制备方法 | |
CN110204742A (zh) | 一种仿眼角膜的高强度电响应润滑水凝胶及其制备方法 | |
CN104448153B (zh) | 一种含磷酸胆碱的高强度聚氨酯水凝胶及其制备方法 | |
CA2786141A1 (en) | Transparent bacterial cellulose nanocomposite hydrogels | |
CN107998451A (zh) | 一种皮肤组织工程支架的3d打印制备方法及该支架的体外细胞毒性测试方法 | |
CN110522947A (zh) | 一种4d-壳聚糖温敏凝胶制备方法 | |
CN112111073B (zh) | 一种抗疲劳的全水凝胶复合材料及其制备方法和应用 | |
CN109206634A (zh) | 明胶基高强度水凝胶及其制备方法 | |
CN109749098A (zh) | 一种物理/化学双交联网络高强度明胶水凝胶及其制备方法 | |
CN109316630A (zh) | 一种生物仿生基质的3d打印墨水及其制备方法 | |
CN111269438A (zh) | 一种取向型微纤维水凝胶及其制备方法 | |
CN106267366B (zh) | 一种利用3d打印制备高强高韧聚离子水凝胶支架的方法 | |
CN108114324A (zh) | 一种基于3d生物打印技术制备皮肤组织工程支架的方法及该支架的体外细胞毒性测试方法 | |
Kunwar et al. | Three-dimensional printing of double-network hydrogels: recent Progress, challenges, and future outlook | |
CN107286359B (zh) | 一种异质多层结构的水凝胶及其制备方法 | |
WO2024109011A1 (zh) | 一种具有定向排列纤维微结构的高强度互穿网络水凝胶血管的制备方法 | |
CN100568056C (zh) | 一种具自抗菌性的软性角膜接触镜及其制备方法和应用 | |
CN109467642A (zh) | 一种可3d打印的高强度温敏超分子水凝胶及其制备方法 | |
CN109758608B (zh) | 具有高韧性的可打印复合水凝胶及制备方法与应用 | |
CN114763399B (zh) | 一种数字光处理3d打印人工角膜及其打印方法和应用 | |
CN109180964A (zh) | 一种丝素蛋白光固化水凝胶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22909383 Country of ref document: EP Kind code of ref document: A1 |